Recent posts

Show more
Repurposing CRISPR: Targeting Chronic UTIs and Blood Infections (2026)
antibiotic resistance 2026

Repurposing CRISPR: Targeting Chronic UTIs and Blood Infections (2026)

Repurposing CRISPR: Targeting Chronic UTIs and Blood Infections (2026) BLUF (Bottom Line Up Front): …

Asad Raza 09:37
Read more
Systemic CRISPR Frontiers: Expanding Treatments into ALS (2026)
AAV9 motor neurons

Systemic CRISPR Frontiers: Expanding Treatments into ALS (2026)

Systemic CRISPR Frontiers: Expanding Treatments into ALS (2026) BLUF (Bottom Line Up Front): The nex…

Asad Raza 09:33
Read more
Securing GMP-Grade Supply Chains for Commercial Gene Therapy (2026)
COI digital tracking

Securing GMP-Grade Supply Chains for Commercial Gene Therapy (2026)

Securing GMP-Grade Supply Chains for Commercial Gene Therapy (2026) BLUF (Bottom Line Up Front): The…

Asad Raza 09:28
Read more
CRISPR Market Forecast 2026-2035: Scaling to a $14B Industry
biotech CAGR 2035

CRISPR Market Forecast 2026-2035: Scaling to a $14B Industry

CRISPR Market Forecast 2026-2035: Scaling to a $14B Industry The global CRISPR gene-editing market is expe…

Asad Raza 09:24
Read more
Outsourcing GMP Manufacturing for CRISPR Clinical Trials (2026)
biotech manufacturing strategy

Outsourcing GMP Manufacturing for CRISPR Clinical Trials (2026)

Outsourcing GMP Manufacturing for CRISPR Clinical Trials (2026) BLUF: To mitigate high clinical tria…

Asad Raza 09:18
Read more
Mitigating High Clinical Trial Costs in Biotech's 2026 Funding Landscape
AI in clinical trials

Mitigating High Clinical Trial Costs in Biotech's 2026 Funding Landscape

Mitigating High Clinical Trial Costs in Biotech's 2026 Funding Landscape In the restrictive 2026 ventu…

Asad Raza 09:05
Read more
Platform Trial Master Protocols: From Single-Disease to Multi-Disease (2026)
basket trials gene therapy

Platform Trial Master Protocols: From Single-Disease to Multi-Disease (2026)

Platform Trial Master Protocols: From Single-Disease to Multi-Disease (2026) To commercialize CRISPR thera…

Asad Raza 08:52
Read more
Load More That is All